Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.07 USD | -4.86% |
|
-6.57% | +14.71% |
07/05 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
07/05 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.71% | 407M | |
+75.67% | 12.57B | |
-25.71% | 7.28B | |
+14.60% | 5.47B | |
-20.44% | 4.73B | |
+14.51% | 4.09B | |
-23.83% | 3.78B | |
-32.59% | 2.63B | |
+28.90% | 2.3B | |
+0.12% | 2.03B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- JPMorgan Downgrades Bioventus to Underweight From Overweight